V de Falco - JoVE Visualize

Showing results (11-20 of 18) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 18 results.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|July 27, 2001

Effect of 17beta-estradiol or alendronate on the bone densitometry, bone histomorphometry and bone metabolism of ovariectomized ratsL H da Paz, V de Falco, N C Teng, et al.

The Journal of Clinical Endocrinology and Metabolism|October 9, 2004

A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failureG Orgiana, G Pinna, A Camedda, et al.

Oncogene|February 28, 2006

Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinomaS Moretti, A Macchiarulo, V De Falco, et al.

Journal of Experimental & Clinical Cancer Research : CR|December 18, 2019

Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpressionS Napolitano, N Matrone, A L Muddassir, et al.

ESMO Real World Data and Digital Oncology|February 6, 2026

Establishment of the Campania Oncology Network (Rete Oncologica Campana, ROC): a paradigm shift in oncological care and real world research in the Campania regionE Coppola, I De Santo, A Luongo, et al.

ESMO Real World Data and Digital Oncology|February 6, 2026

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approachE Cioli, G Suarato, R Napolitano, et al.

ESMO Gastrointestinal Oncology|April 17, 2026

Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancerV De Falco, P P Vitiello, D Ciardiello, et al.

ESMO Open|October 29, 2025

Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapyL Boscolo Bielo, S Napolitano, A Avallone, et al.

Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 18 results.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|July 27, 2001

Effect of 17beta-estradiol or alendronate on the bone densitometry, bone histomorphometry and bone metabolism of ovariectomized ratsL H da Paz, V de Falco, N C Teng, et al.

The Journal of Clinical Endocrinology and Metabolism|October 9, 2004

A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failureG Orgiana, G Pinna, A Camedda, et al.

Oncogene|February 28, 2006

Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinomaS Moretti, A Macchiarulo, V De Falco, et al.

Journal of Experimental & Clinical Cancer Research : CR|December 18, 2019

Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpressionS Napolitano, N Matrone, A L Muddassir, et al.

ESMO Real World Data and Digital Oncology|February 6, 2026

Establishment of the Campania Oncology Network (Rete Oncologica Campana, ROC): a paradigm shift in oncological care and real world research in the Campania regionE Coppola, I De Santo, A Luongo, et al.

ESMO Real World Data and Digital Oncology|February 6, 2026

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approachE Cioli, G Suarato, R Napolitano, et al.

ESMO Gastrointestinal Oncology|April 17, 2026

Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancerV De Falco, P P Vitiello, D Ciardiello, et al.

ESMO Open|October 29, 2025

Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapyL Boscolo Bielo, S Napolitano, A Avallone, et al.

Pageof 2